You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

CORTICOTROPIN - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for corticotropin and what is the scope of patent protection?

Corticotropin is the generic ingredient in seven branded drugs marketed by Parkedale, Sanofi Aventis Us, Mallinckrodt Ard, Organics Lagrange, Watson Labs, and Ani Pharms, and is included in seven NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are ten drug master file entries for corticotropin. Two suppliers are listed for this compound.

Recent Clinical Trials for CORTICOTROPIN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Rutgers, The State University of New JerseyPhase 2
Yangzhou UniversityN/A
Feinstein Institute for Medical ResearchPhase 2

See all CORTICOTROPIN clinical trials

Pharmacology for CORTICOTROPIN

US Patents and Regulatory Information for CORTICOTROPIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Organics Lagrange CORTICOTROPIN corticotropin INJECTABLE;INJECTION 010831-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Mallinckrodt Ard ACTHAR GEL (AUTOINJECTOR) corticotropin INJECTABLE;INJECTION 008372-003 Feb 29, 2024 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Ani Pharms CORTROPHIN-ZINC corticotropin-zinc hydroxide INJECTABLE;INJECTION 009854-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Parkedale ACTH corticotropin INJECTABLE;INJECTION 008317-004 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Mallinckrodt Ard ACTHAR GEL corticotropin INJECTABLE;INJECTION 008372-008 Approved Prior to Jan 1, 1982 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Organics Lagrange CORTICOTROPIN corticotropin INJECTABLE;INJECTION 010831-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.